Exact Mass: 432.1158436
Exact Mass Matches: 432.1158436
Found 51 metabolites which its exact mass value is equals to given mass value 432.1158436,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-(Perfluorohexyl)octane
C14H17F13 (432.11225979999995)
Ulixertinib
C21H22Cl2N4O2 (432.11197319999997)
Trichodermamide A
C20H20N2O9 (432.11687500000005)
CONFIDENCE Penicillium corvianum
Calomelanol G
beta-(5,7,4-trihydroxy-flavon-8-yl)-beta-phenylpropionic acid methyl ester
(7R)-8-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]galangin
Me ester-5, 7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-beta-phenyl-4H-1-benzopyran-8-propanoic acid
Ala Cys Cys His
Ala Cys His Cys
Ala His Cys Cys
Cys Ala Cys His
Cys Ala His Cys
Cys Cys Ala His
Cys Cys His Ala
Cys His Ala Cys
Cys His Cys Ala
His Ala Cys Cys
His Cys Ala Cys
His Cys Cys Ala
TyrMe-Asp-OH
C20H20N2O9 (432.11687500000005)
1-ethyl-2-[3-(1-ethylquinolin-1-ium-2-yl)prop-2-enylidene]quinoline,bromide
3-((3-((tert-Butyldimethylsilyloxy)methyl)-pyrrolidin-1-yl)methyl)-5-iodopyridine
C17H29IN2OSi (432.10938139999996)
GSK429286A
C21H16F4N4O2 (432.12093239999996)
bis(4-(4-aminophenoxy)phenyl)sulfone
C24H20N2O4S (432.11437200000006)
5-CHLORO-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLO[2,3-B]PYRIDINE
C20H22BClN2O4S (432.10817920000005)
Torin 2
Torin 2 is an mTOR inhibitor with EC50 of 0.25 nM for inhibiting cellular mTOR activity, and exhibits 800-fold selectivity over PI3K (EC50: 200 nM). Torin 2 also inhibits DNA-PK with an IC50 of 0.5 nM in the cell free assay. Torin 2 can suppress both mTORC1 and mTORC2. Torin 2 is an mTOR inhibitor with EC50 of 0.25 nM for inhibiting cellular mTOR activity, and exhibits 800-fold selectivity over PI3K (EC50: 200 nM). Torin 2 also inhibits DNA-PK with an IC50 of 0.5 nM in the cell free assay. Torin 2 can suppress both mTORC1 and mTORC2.
Ulixertinib
C21H22Cl2N4O2 (432.11197319999997)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line[1][2].
Ethyl 1-thio-beta-D-galactopyranoside 2,3-dibenzoate
3,3-[Sulfonylbis(4,1-phenyleneoxy)]dianiline
C24H20N2O4S (432.11437200000006)
4-(4-Methoxyphenyl)-3-(4-methylphenyl)-5-[(4-nitrophenyl)methylthio]-1,2,4-triazole
C23H20N4O3S (432.12560500000006)
N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide
C23H20N4O3S (432.12560500000006)
N-[(E)-[3-(4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylideneamino]benzenesulfonamide
C23H20N4O3S (432.12560500000006)
4-[[1-(2-Furanylmethyl)-2,4,6-trioxo-3-propan-2-yl-1,3-diazinan-5-ylidene]methylamino]benzenesulfonamide
C19H20N4O6S (432.11035000000004)
2-[(3S,6aR,8R,10aR)-1-(2-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide
C18H25ClN2O6S (432.11217800000003)
[2-ethoxy-4-[(Z)-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)methyl]phenyl] thiophene-2-carboxylate
C24H20N2O4S (432.11437200000006)
FABP-IN-2
FABP-IN-2 is a novel FABP3 ligand. FABP-IN-2 inhibits FABP3/FABP4 with an IC50 of 1.16 μM and 4.27 μM respectively[1].
Plazinemdor
C21H19ClF2N4O2 (432.11645280000005)
Plazinemdor is a N-methyl-D-aspartate(NMDA) receptor positive allosteric modulator. Plazinemdor can be uses in the research of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system[1]..
(4as,5r,8r,8as)-n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide
C20H20N2O9 (432.11687500000005)
(7s,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-(4-methoxyphenyl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1(10),2,8-triene-5,11-dione
methyl 3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-3-phenylpropanoate
octacyclo[15.13.1.1²²,²⁶.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²¹,³¹.0³⁰,³²]dotriaconta-1,3,5(14),6(11),9,12,15,17(31),18,20,22(32),23,25,27,29-pentadecaene-7,8-dione
(7r,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-(4-methoxyphenyl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1(10),2,8-triene-5,11-dione
n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide
C20H20N2O9 (432.11687500000005)